Jan 03, 2019 4:15pm EST MRI Interventions Announces Estimated 30% Growth Driven by Record Revenue and Record ClearPoint® Procedure Volume in 2018 Fourth Quarter
Jan 03, 2019 4:05pm EST MRI Interventions Receives FDA Clearance for ClearPoint® PURSUIT™ Neuro Aspiration System
Dec 10, 2018 4:42pm EST MRI Interventions Congratulates Voyager Therapeutics on First Patient Dosing in RESTORE-1, the Phase 2 VY-AADC Gene Therapy Trial for Parkinson’s Disease
Nov 12, 2018 4:05pm EST MRI Interventions Reports Record ClearPoint® Cases and Disposable Functional Neurosurgery Revenue in Third Quarter
Nov 06, 2018 4:11pm EST MRI Interventions Announces FDA Clearance of ClearPoint® 2.0 Next-Generation Software Platform
Nov 05, 2018 4:05pm EST MRI Interventions, Inc. to Announce Third Quarter 2018 Results on November 12
Oct 25, 2018 4:05pm EDT MRI Interventions Congratulates Axovant on First Patient Dosing in New Gene Therapy Clinical Study for Patients with Parkinson’s Disease
Oct 24, 2018 4:05pm EDT MRI Interventions Congratulates Monteris Medical on FDA Clearance of NeuroBlate Laser Probe
Oct 19, 2018 7:30am EDT MRI Interventions Signs Exclusive Distribution Agreement with Clinical Laserthermia Systems (CLS) for U.S. and Canada